https://www.selleckchem.com/pr....oducts/ferrostatin-1
The Cardiac Lipid Panel (CLP) is a newly discovered panel of metabolite-based biomarkers that has shown to improve the diagnostic value of N terminal pro B type natriuretic peptide (NT-proBNP). However, little is known about its usefulness in predicting outcomes. In this study, we developed a risk score for 4-year cardiovascular death in elderly chronic heart failure (CHF) patients using the CLP. From the Cardiac Insufficiency Bisoprolol Study in Elderly trial, we included 280 patients with CHF aged 65 years. A targeted metabo
Like
Comment
Share
